These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 854885)

  • 1. Effect of suloctidil on bleeding time and in vivo platelet aggregation in rats.
    de Gaetano G; Cavenaghi AE
    Thromb Res; 1977 Mar; 10(3):525-30. PubMed ID: 854885
    [No Abstract]   [Full Text] [Related]  

  • 2. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by suloctidil of arterial thrombus formation in rats (a).
    Roba J; Bourgain R; Andries R; Claeys M; Van Opstal W; Lambelin G
    Thromb Res; 1976 Dec; 9(6):585-94. PubMed ID: 1006627
    [No Abstract]   [Full Text] [Related]  

  • 4. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
    Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxal 5'-phosphate--a new physiological inhibitor of blood coagulation and platelet function.
    Subbardo K; Kuchibhotla J; Kakkar VV
    Biochem Pharmacol; 1979; 28(4):531-4. PubMed ID: 426874
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
    Nakashima M; Uematsu T; Takiguchi Y; Mizuno A; Uchida K; Matsubara T
    J Clin Pharmacol; 1988 Mar; 28(3):253-8. PubMed ID: 3162917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation.
    Doutremepuich C; de Sèze O; Le Roy D; Lalanne MC; Anne MC
    Haemostasis; 1990; 20(2):99-105. PubMed ID: 2347518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clonixin and aspirin on platelet aggregation in human volunteers.
    Arkel YS; Schrogie JJ; Williams R
    J Clin Pharmacol; 1976 Jan; 16(1):30-3. PubMed ID: 1245606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet and antithrombogenic effects of suloctidil.
    Roba J; Claeys M; Lambelin G
    Eur J Pharmacol; 1976 Jun; 37(2):265-74. PubMed ID: 821760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ethanol extract of Ramulus mori improves blood circulation by inhibiting platelet aggregation.
    Lee J; Kwon G; Park J; Kim JK; Choe SY; Seo Y; Lim YH
    Biosci Biotechnol Biochem; 2016 Jul; 80(7):1410-5. PubMed ID: 26967156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (Wy-23,049)--comparison with acetylsalicylic acid.
    Fenichel RL; Dougherty JA; Alburn HE
    Biochem Pharmacol; 1974 Dec; 23(23):3273-82. PubMed ID: 4374215
    [No Abstract]   [Full Text] [Related]  

  • 14. Low dose infusion of adenosine diphosphate prolongs bleeding time in rats and rabbits.
    Aursnes I; Stenberg-Nilsen H
    Thromb Res; 1992 Oct; 68(1):67-74. PubMed ID: 1448798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets.
    Joist JH; Dolezel G; Kinlough-Rathbone R; Mustard JF
    Thromb Res; 1976 Nov; 9(5):435-45. PubMed ID: 996831
    [No Abstract]   [Full Text] [Related]  

  • 16. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosity.
    Small M; Douglas JT; Aherne GW; Orr M; Lowe GD; Forbes CD; Prentice CR
    Thromb Res; 1982 Feb; 25(4):351-60. PubMed ID: 6122288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of suloctidil on platelet survival time following cardiac valve replacement.
    Col-de Beys C; Ferrant A; Moriau M
    Thromb Haemost; 1981 Aug; 46(2):550-3. PubMed ID: 6272442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of S-8527 (1, 1-bis (4'-(1"-carboxy-1"-methylpropoxy) phenyl) cyclohexane), a new hypolipidemic compound, on platelet aggregation, adhesiveness and blood coagulation in rats.
    Suzuki K
    Jpn J Pharmacol; 1975 Aug; 25(4):393-9. PubMed ID: 1206811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.